Patents by Inventor Neelufar Mozaffarian

Neelufar Mozaffarian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection and treatment of autoimmune disorders
    Patent number: 11860161
    Abstract: Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing a PD1 ligand.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: January 2, 2024
    Assignee: Seattle Children's Hospital
    Inventors: Neelufar Mozaffarian, Anne M. Stevens
  • DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20200209237
    Abstract: Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing a PD1 ligand.
    Type: Application
    Filed: August 5, 2019
    Publication date: July 2, 2020
    Applicant: Seattle Children's Hospital
    Inventors: Neelufar Mozaffarian, Anne M. Stevens
  • COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES
    Publication number: 20190314382
    Abstract: The present invention relates to the use of compounds or pharmaceutical compositions comprising the same, and methods of treatment using the same, in the prophylaxis and/or treatment of alopecia areata, vitiligo, cutaneous lupus, lupus nephritis, giant cell arteritis, sarcoïdosis and/or sarcoïdosis-related conditions. In particular the compounds are JAK inhibitors.
    Type: Application
    Filed: November 9, 2017
    Publication date: October 17, 2019
    Inventors: Chantal Thérèse TASSET, Pille HARRISON, René Alexandre GALIEN, John Sargent SUNDY, John G. MCHUTCHISON, Thomas O'RIORDAN, Neelufar MOZAFFARIAN, Uptal Dinesh PATEL, Timothy R. WATKINS, David L. GOSSAGE
  • Detection and treatment of autoimmune disorders
    Patent number: 10371702
    Abstract: Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing a PD1 ligand.
    Type: Grant
    Filed: October 5, 2015
    Date of Patent: August 6, 2019
    Assignee: SEATTLE CHILDREN'S HOSPITAL
    Inventors: Neelufar Mozaffarian, Anne M. Stevens
  • IL-21 antibodies and methods of making or using the antibodies
    Patent number: 9394362
    Abstract: The invention relates to engineered, humanized antibodies that have high binding affinity for and neutralize human IL-21, methods of using the antibodies to treat conditions in which antagonism or neutralization of the effects of IL-21 is warranted, such as autoimmune conditions, compositions and methods for recombinantly producing the antibodies, and pharmaceutical compositions comprising the antibodies.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: July 19, 2016
    Assignee: Eli Lilly and Company
    Inventors: Julian Davies, Fabio Magrini, Andrea Paula Martin, Neelufar Mozaffarian, Chetankumar N. Patel, Oliver Schroeder
  • DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20160131646
    Abstract: Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing a PD1 ligand.
    Type: Application
    Filed: October 5, 2015
    Publication date: May 12, 2016
    Applicant: Seattle Children's Hospital
    Inventors: Neelufar Mozaffarian, Anne M. Stevens
  • Detection and treatment of autoimmune disorders
    Patent number: 9168296
    Abstract: Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing a PD1 ligand.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: October 27, 2015
    Assignee: SEATTLE CHILDREN'S HOSPITAL
    Inventors: Neelufar Mozaffarian, Anne M. Stevens
  • IL-21 ANTIBODIES
    Publication number: 20150266954
    Abstract: The invention relates to engineered, humanized antibodies that have high binding affinity for and neutralize human IL-21, methods of using the antibodies to treat conditions in which antagonism or neutralization of the effects of IL-21 is warranted, such as autoimmune conditions, compositions and methods for recombinantly producing the antibodies, and pharmaceutical compositions comprising the antibodies.
    Type: Application
    Filed: March 13, 2015
    Publication date: September 24, 2015
    Inventors: Julian Davies, Fabio Magrini, Andrea Paula Martin, Neelufar Mozaffarian, Chetankumar N. Patel, Oliver Schroeder
  • DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20120130350
    Abstract: Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing a PD1 ligand.
    Type: Application
    Filed: October 26, 2011
    Publication date: May 24, 2012
    Inventors: Neelufar Mozaffarian, Anne M. Stevens
  • Detection and treatment of autoimmune disorders
    Patent number: 8062852
    Abstract: Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing the involving a PD1 ligand.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: November 22, 2011
    Assignee: The Children's Hospital and Regional Medical Center
    Inventors: Neelufar Mozaffarian, Anne M. Stevens
  • DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20090110667
    Abstract: Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing the involving a PD1 ligand.
    Type: Application
    Filed: October 1, 2008
    Publication date: April 30, 2009
    Applicant: Children's Hospital and Reginonal Medical Center
    Inventors: Neelufar Mozaffarian, Anne M. Stevens